Transition Bio Overview
- Founded
- 2020
- Status
- Private
- Employees
- 2
- Latest Deal Type
- Seed
- Latest Deal Amount
- $9M
- Investors
- 1
Transition Bio General Information
Description
Operator of a biotechnology company dedicated to build a hypothesis-free drug discovery and diagnostics platform for human health care advancement. The company harnesses droplet microfluidic approaches and protein biophysics platforms to characterize condensates with unprecedented precision, thereby enabling medical practitioners to map condensates in molecular detail.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Cambridge, MA
- United States
Transition Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 01-Sep-2020 | $9M | 000 | 0000 | Completed | Startup |
Transition Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Transition Bio Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| David Weitz Ph.D | Co-Founder and Board Member | ||
| Tuomas Knowles Ph.D | Co-Founder and Board Member |
Transition Bio Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Weitz Ph.D | Transition Bio | Co-Founder and Board Member | 000 0000 |
| David Zimble | Transition Bio | Board Member | 000 0000 |
| Samuel Cohen | Transition Bio | Board Member | 000 0000 |
| Tuomas Knowles Ph.D | Transition Bio | Co-Founder and Board Member | 000 0000 |
Transition Bio Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTransition Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Lifeforce Capital | Venture Capital | Minority | 000 0000 | 000000 0 |